RIL
STOK icon

Rothschild Investment LLC’s Stoke Therapeutics STOK Stock Holding History

Rothschild Investment LLC’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.49K Sell
290
-1
-0.3% -$32 ﹤0.01% 1910
2026
Q1 		$9.47K Sell
291
-2
-0.7% -$66 ﹤0.01% 1709
2025
Q4 		$9.3K Buy
293
+3
+1% +$90 ﹤0.01% 1597
2025
Q3 		$6.82K Sell
290
-40
-12% -$685 ﹤0.01% 1586
2025
Q2 		$3.75K Buy
330
+305
+1,220% +$2.9K ﹤0.01% 1654
2025
Q1 		$166 Sell
25
-25
-50% -$233 ﹤0.01% 2888
2024
Q4 		$552 Buy
50
+10
+25% +$123 ﹤0.01% 2495
2024
Q3 		$492 Buy
40
+10
+33% +$142 ﹤0.01% 2469
2024
Q2 		$405 Buy
+30
New +$405 ﹤0.01% 2151

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rothschild Investment LLC's STOK Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Stoke Therapeutics (STOK) stake by 0.34% in Q2 2026, selling an estimated $32 and leaving 290 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Rothschild Investment LLC first reported a position in STOK in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Rothschild Investment LLC held 290 shares of Stoke Therapeutics worth $9.49K as of Q2 2026.
  • Rothschild Investment LLC sold 1 Stoke Therapeutics share in Q2 2026, an estimated $32.
  • Stoke Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1910 holding.
  • Rothschild Investment LLC first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.